LabCorp’s newly-launched test offering to have future applications in clinical research

By Melissa Fassbender

- Last updated on GMT

Pixel by LabCorp (Image: Business Wire)
Pixel by LabCorp (Image: Business Wire)

Related tags LabCorp Covance Testing

LabCorp has launched Pixel by LabCorp, a consumer-initiated wellness test offering that allows for sample self-collection and access to online results.

During the company’s most recent earnings call​, LabCorp CEO David King said the company was preparing to launch the wellness testing offering. As he explained at the time, the offering will be expanded and will have application in its drug development business, Covance.

The offering falls in line with the company’s aim to support trials with “convenient, accurate testing outside the physician office,”​ King said.

“The ability to make testing more accessible and convenient can help support clinical research in a variety of ways, from initial eligibility screening to remote patient monitoring,”​ Donald Von Hagen, LabCorp, vice president, corporate communications, told us.

“We plan to pursue these types of opportunities in the future as we continue to develop Pixel by LabCorp,”​ he said.

The test packages can be purchased at and include a physician review and order, which are required for all Pixel by LabCorp testing, the company explained. Most testing requires a few drops of blood collected from the fingertip.

The offering will initially provide screens for wellness, heart health, diabetes, and colorectal cancer.

Related news

Show more

Related products

show more

Drug Solubility and the Need for Speed

Drug Solubility and the Need for Speed

Lonza Small Molecules | 28-Mar-2023 | Technical / White Paper

A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways...

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

4 Warning Signs Your Research Site Is in Trouble

4 Warning Signs Your Research Site Is in Trouble

Elligo Health Research® | 10-Mar-2023 | Insight Guide

You want your clinical research practice to be a success for your business and your patients, but how can you tell if it’s in trouble? Read this article...

Related suppliers

Follow us


View more